Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F(2α) binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: Characterization and correlation with functional data

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 1094-1102

  Sharif, N A ^a   Xu, S X ^a   Williams, G W ^a   Crider, J Y ^a   Griffin, B W ^a   Davis, T L ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 17 PHENYLPROSTAGLANDIN E2; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 8 ISOPROSTAGLANDIN F2 ALPHA; 9BETA CHLORO 15 CYCLOHEXYL 9 DEOXY 16,17,18,19,20 PENTANOR 3 OXAPROSTAGLANDIN F2 ALPHA; ANANDAMIDE; BUTAPROST; CLOPROSTENOL; ENPROSTIL; FLUPROSTENOL; GR 63799; ILOPROST; LATANOPROST; MISOPROSTOL; PHXA 85; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; RECEPTOR SUBTYPE; S 1033; SC 46275; SULPROSTONE; TRITIUM; UNCLASSIFIED DRUG; UNOPROSTONE ISOPROPYL ESTER; PHOSPHATIDYLINOSITOL; PROSTAGLANDIN E RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CATTLE; CONTROLLED STUDY; CORPUS LUTEUM; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RECEPTOR DENSITY; ANIMAL; AUTORADIOGRAPHY; DRUG EFFECT; IN VITRO STUDY; KINETICS; MEMBRANE; METABOLISM;

ALPROSTADIL; ANIMALS; AUTORADIOGRAPHY; CATTLE; CORPUS LUTEUM; DINOPROST; DINOPROSTONE; FEMALE; KINETICS; MEMBRANES; PHOSPHATIDYLINOSITOLS; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E;

EID: 0032219624     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM and Grygorczyk R (1994) Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269:2632-2636.
2. Andersen NH and Ramwell PW (1974) Biological aspects of prostaglandins. Arch Intern Med 133:30-50.
3. 2α binding sites in subpopulation of ovine luteal cells. Biol Reprod 41:385-392.
4. Berridge MJ, Downes CP and Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidyinositol responses in brain and salivary gland. Biochem J 206:587-595.
5. 1C-adrenoceptors: studies in the isolated perfused kidney of rat. Br J Pharmacol 115:283-294.
6. Chegini N, Lei ZM, Rao, Ch. V and Hansel W (1991) Cellular distribution and cycle phase dependency of gonadotropin and eicosanoid binding sites in bovine corpora lutea. Biol Reprod 45:506-513.
7. Coleman RA, Smith WL and Narumiya S (1994) VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229.
8. Custer EE, Lamsa JC, Eldering JA and McCracken JA (1995) Identification of functional high and low affinity states of the prostaglandin F2 alpha receptor in the ovine corpus luteum in vivo and their role in hormone pulsatility. Endrocrine 3:761-764.
9. 2+ in bovine luteal cells. Proc Natl Acad Sci USA 84:3728-3732.
10. Goh Y and Kishino J (1994) Pharmacological characterization of prostaglandin-related ocular hypotensive agents. Jpn J Ophthalmol 38:236-245.
11. Griffin BW, Williams GW, Crider JY and Sharif NA (1997) FP prostaglandin receptors mediating inositol phosphate generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study. J Pharmacol Exp Ther 281:845-854.
12. 2 on the human corpus luteum of the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 66:909-914.
13. Hammarstrom S, Powell WS, Kylden U and Samuelsson B (1976) Some properties of a prostaglandin F2 receptor in corpora lutea, in Advances in Prostaglandin and Thromboxane Research , Vol 1 (Samuelsson B and Paoletti R eds), pp 235-246, Raven Press, New York.
14. Harrison LM, Kenny N and Niswender GD (1987) Progesterone production, LH receptors, and oxytocin secretion by ovine luteal cell types on days 6, 10 and 15 of the oestrous cycle and day 25 of pregnancy. J Reprod Fertil 79:539-548.
15. 2α specific binding in bovine corpora lutea: comparison with luteolytic effects. Prostaglandins 10:313-331.
16. Kiriyama M, Ubikubi F, Kobatashi T, Hirata M, Sugimoto Y and Narumiya S (1997) Ligand binding specificities of the eight types and subtypes of mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122:217-224.
17. 3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 48:869-879.
18. Marsh J (1970) The effects of prostaglandins on the adenyl cyclase of the bovine corpus luteum. Ann NY Acad Sci 180:416- 425.
19. McPherson GA (1983) A practical computer based approach to the analysis of radioligand binding experiments. Comput Prog Biomed 17:107-114.
20. 2α on dispersed marmoset luteal cells are differentially mediated via cyclic AMP and protein kinase C. J Endocrinol 138:291-298.
21. 3 determines G-protein specificity. Nature 365:166-170.
22. 3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding. Biochim Biophys Acta 1175:343-350.
23. 3 receptor. Prostaglandins 48:275-283.
24. Niswender GD and Nett TM (1988) Corpus luteum and its control, in The Physiology of Reproduction (Knobll E and Neil J eds) New York, Raven Press, pp. 489-525.
25. Powell WS, Hammarstrom S, Samuelsson B, Miller WL, Sun FF, Fried J, Lin CH and Jarabak J (1975) Interaction between prostaglandin analogues and a receptor in bovine corpora lutea. Correlation of dissociation constants with luteolytic potencies in hamsters. Eur J Biochem 59:271-276.
26. 2α receptor in bovine corpus luteum plasma membranes. Eur J Biochem 61:605-611.
27. Rao, Ch. V (1976) Discrete prostaglandin receptors in the outer cell membranes of bovine corpora lutea. Advan Prostagland Thromboxane Res 1:247-258.
28. 2α binding sites in human corpora lutea. J Clin Endocrinol Metab 44:1032-1037.
29. 2α receptor. J Biol Chem 269:3881-3886.
30. Sakurai M, Araie U, Oshika MT, Mori M, Masuda K, Ueno R and Takase M (1991) Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 35:156-165.
31. Sander H, Bruhn T and Ellendorf F (1982) Prostaglandin E (sulproston) is neither luteolytic nor luteotrophic during the estrous cycle in the pig. Prostaglandins 24:691-700.
32. Sharif NA (1996) Quantitative autoradiographic methods, in Brain Mapping: The Methods (Toga AW and Mazziota JC eds.) pp 115-144, Academic Press Inc., New York.
33. Sharif NA and Hughes J (1989) Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10:499-522.
34. Sharif NA, Xu SX, Miller ST, Gamache DA and Yanni JM (1996) Characterization of the ocular anti-allergic and anti-histaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278:1252-1261.
35. Sharif NA, Crider JY, Griffin BW, Davis TL and Howe WE (1997) Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J Ocular Pharmacol Ther 13:321-336.
36. 2α analogue. Adv Prostagland Thrombox Leukotr Res 23:513-518.
37. 2α receptor. J Biol Chem 269:1356-1360.
38. 2α receptor in bovine preovulatory follicles. Endocrinology 137:3348-3355.
39. 2, and their esters in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 31:2466-2470.
40. 2α to membranes of rat corpora lutea. Mol Cell Endocrinol 13:25-34.